Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2697
Source ID: NCT00309192
Associated Drug: Triamcinolone Acetonide
Title: Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus|Macular Edema
Interventions: DRUG: Triamcinolone Acetonide|PROCEDURE: Grid laser|PROCEDURE: Sham Injection
Outcome Measures: Primary: Visual acuity stabilization or improvement 6 months after treatment., 6 months|Macular edema reduction or stabilization 6 months after treatment., 6 months | Secondary: Safety of the treatment., 6 months|Tolerance of the treatment., 6 months
Sponsor/Collaborators: Sponsor: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | Collaborators: Fondo de Investigacion Sanitaria
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 292
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2006-04
Completion Date: 2009-07
Results First Posted:
Last Update Posted: 2023-03-14
Locations: INGO - Instituto Galego de Oftalmoloxia, Santiago de Compostela, La Coruña, Spain|Clínica Universitaria de Navarra, Pamplona, Navarra, Spain|Instituto Oftalmológico de Alicante, Alicante, Spain|Hospital de la Vall D´Hebrón, Barcelona, Spain|Hospital Clínico Universitario San Carlos, Madrid, Spain|Hospital General Universitario Reina Sofía, Murcia, Spain|IOBA - Instituto Universitario de Oftalmobiología Aplicada, Valladolid, 47011, Spain
URL: https://clinicaltrials.gov/show/NCT00309192